期刊文献+

microRNA-10b与胰腺癌吉西他滨耐药的相关性及机制研究 被引量:1

Relationship between microRNA-10b and chemoresistance of pancreatic cancer to gemcitabine and its possible mechanism
分享 导出
摘要 目的:探讨microRNA-10b(miR-10b)与胰腺癌细胞吉西他滨(gemcitabine,GEM)化疗耐药的相关性及可能机制。方法:RT-qPCR检测吉西他滨相对耐药的胰腺癌细胞株PANC-1及吉西他滨相对敏感的CFPAC-1中miR-10b的表达情况;用不同浓度的吉西他滨作用于上述细胞,RT-qPCR检测二者miR-10b的表达变化;CFPAC-1细胞转染miR-10b mimics上调miR-10b表达量,CCK-8法及流式细胞仪检测细胞对吉西他滨药物敏感性的变化,Western blot检测抗凋亡相关蛋白(如PI3K、p-Akt、Bcl-2、Survivin)的表达,RT-qPCR检测PTEN基因的表达变化。结果:PANC-1细胞中miR-10b的表达显著高于CFPAC-1细胞,且上述两种细胞中miR-10b的表达量与吉西他滨呈浓度梯度依赖;高表达miR-10b后CFPAC-1细胞对吉西他滨的敏感性下降,PI3K、p-Akt、Bcl-2、Survivin蛋白的表达升高,PTEN mRNA的表达水平降低。结论:miR-10b可能通过负性调控PTEN的表达水平,从而增加PI3K、p-Akt、Bcl-2、Survivin蛋白的表达,减少凋亡来降低CFPAC-1对吉西他滨的敏感性,最终导致胰腺癌细胞对吉西他滨化疗耐受。 Objectives:To reveal the relationship between mieroRNA-10b and gemcitabine (GEM) resistance of pancreatic cancer and its possible mechanism. Methods: The expression of mieroRNA-10b in PANC-1 cells (which are relatively resistant to GEM) and CFPAC-1 cells (which are relatively sensitive to GEM) were detected by RT-qPCR. PANC-1 and CFPAC-1 cells were treated with dif- ferent doses of GEM,and then the cells were harvested. The expression of mieroRNA-10b was detected by RT-qPCR. CCK-8 assay and flow eytometry were performed to evaluate the drug sensitivity of CFPAC-1 cells,which were transfected with mieroRNA-10b mimics to GEM. The protein expressions of PI3K, p-Akt, Bcl-2 and Survivin in CFPAC-1 cells transfected with microRNA-10b mimics or negative control were demonstrated using Western blotting assay. The gene expressions of PTEN in CFPAC-1 cells transfected with microRNA-10b mimics or negative control were detected by RT-qPCR. Results: PANC-1 cells showed significantly increased expres- sion of microRNA-10b as compared to CFPAC-I cells. The expression of microRNA-10b both in PANC-1 and CFPAC-1 cells in- creased with the rising of GEM concentration. The sensitivity of CFPAC-l cells to GEM decreased when microRNA-10b was overex- pressed and the expressions of PI3K, p-Akt, Bcl-2, and Survivin were much higher than their control groups. The expression of PTEN mRNA decreased as microRNA-10b increased. Conclusions: MicroRNA-10b might negatively regulate the gene expression of PTEN, which increases the protein expressions of PI3K,p-Akt,Bcl-2 and Survivin,thus reduces the sensitivity of CFPAC-1 cells to GEM,and as a result,pancreatic cancer cells become resistant to GEM.
作者 顾燊 邵欣宇 邹晓平 Gu Shen1,2, Shao Xinyu1, Zou Xiaoping3. (1.Drum Tower School of Medicine ,NJMU, Nanjing 210008 ;2.Department of Gastroenterdogy, Qidong People's Hos- pital, Qidong 226200;3.Department of Gastroenterology,the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China)
出处 《南京医科大学学报:自然科学版》 CSCD 北大核心 2017年第7期830-835,共6页 Acta Universitatis Medicinalis Nanjing
基金 [基金项目]江苏省医学领军人才与创新团队(LJ201104)
关键词 microRNA-10b 胰腺癌 吉西他滨 化疗耐药 microRNA-10b pancreatic cancer gemcitabine chemoresistance
作者简介 通信作者,E-mail:13770771661@163.com
  • 相关文献

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈